Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR)
| Autor: | Jorge Federico Elgart, Juan José Gagliardino, Enzo Rucci, C. Cernadas, Lorena Gonzalez, Joaquín E. Caporale, G. Pfirter, Claudio Gonzalez, M. Villagra, Silvia Gorbán de Lapertosa, Charles M. Clark |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Patient Dropouts Endocrinology Diabetes and Metabolism Psychological intervention MEDLINE Argentina Hyperlipidemias Type 2 diabetes Health Promotion law.invention Diabetes Complications Endocrinology Randomized controlled trial Patient Education as Topic law General Practitioners Diabetes mellitus Internal Medicine medicine Humans Aged Glycated Hemoglobin Primary Health Care business.industry Public health Health Care Costs Middle Aged medicine.disease Blood pressure Diabetes Mellitus Type 2 Hyperglycemia Hypertension Physical therapy Costs and Cost Analysis Education Medical Continuing Female business Patient education Follow-Up Studies |
| Zdroj: | Diabetic medicine : a journal of the British Diabetic Association. 30(9) |
| ISSN: | 1464-5491 |
| Popis: | Aim To evaluate the effect of system interventions (formalized data collection and 100% coverage of medications and supplies) combined with physician and/or patient education on therapeutic indicators and costs in Type 2 diabetes. Methods This was a randomized 2 × 2 design in public health, social security or private prepaid primary care clinics in Corrientes, Argentina. Thirty-six general practitioners and 468 adults with Type 2 diabetes participated. Patients of nine participating physicians were selected randomly and assigned to one of four structured group education programmes (117 patients each): control (group 1), physician education (group 2), patient education (group 3), and both physician education and patient education (group 4), with identical system interventions in all four groups. Outcome measures included HbA1c, BMI, blood pressure, fasting glucose, lipid profile, drug consumption, resource use and patient well-being at baseline and every 6 months up to 42 months. Results HbA1c decreased significantly from 4 mmol/mol to 10 mmol/mol by 42 months (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text